Pemetrexed in Previously Treated Non-small Cell Lung Cancer Patients with Poor Performance Status

Pemetrexed in Previously Treated Non-small Cell Lung Cancer Patients with Poor Performance Status

Background and objective Pemetrexed have been approved for the treatment of patients affected by advanced non-small cell lung cancner (NSCLC) in progression after first-line chemotherapy. We evaluated the activity and feasibility of pemetrexed in previously treated NSCLC. Methods Patients with histo...

Full description

Bibliographic Details
Main Authors: Sun Young JUNG, Su Jin YOO, Ji Young SHIN, Ji Won PARK, Jeong Eun LEE, Hee Sun PARK, Ju Ock KIM, Sun Young KIM
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2011-01-01
Series:Chinese Journal of Lung Cancer
Subjects:
Pemetrexed
Lung neoplasms
Poor performance
Online Access:http://www.lungca.org/index.php?journal=01&page=article&op=viewFile&path[]=10.3779%2Fj.issn.1009-3419.2011.01.07&path[]=3088

Internet

http://www.lungca.org/index.php?journal=01&page=article&op=viewFile&path[]=10.3779%2Fj.issn.1009-3419.2011.01.07&path[]=3088

Similar Items